Varonis Systems Faces Securities Lawsuit Over SaaS Transition Disclosures

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Varonis Systems faces securities lawsuit alleging executives failed to disclose weakening renewal rates and overstated SaaS transition progress, leading to 48% stock decline and $3.8 billion market cap loss.

Varonis Systems Faces Securities Lawsuit Over SaaS Transition Disclosures

Varonis Systems Inc. is the subject of a securities class action lawsuit alleging that company executives failed to adequately disclose weakening renewal rates within its Federal vertical and legacy on-premises business segments while simultaneously overstating progress in its strategic shift toward Software-as-a-Service offerings. The litigation centers on claims that material information regarding conversion challenges was withheld from investors during the period preceding a significant public disclosure.

On October 28, 2025, Varonis announced lower-than-expected conversion metrics and substantially reduced forward guidance, triggering a sharp market reaction. The stock declined 48% in a single trading session, resulting in approximately $3.8 billion in lost market capitalization. The precipitous decline underscores investor concerns regarding the accuracy and timeliness of prior disclosures regarding the company's business performance and strategic transition initiatives.

Investors seeking to participate in the class action have until March 9, 2026 to establish their eligibility as lead plaintiffs. The lawsuit represents a standard mechanism for shareholders to seek damages related to alleged misstatements or omissions in company disclosures during the relevant period.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 25

Related Coverage

GlobeNewswire Inc.

Inovio Investors Face April 7 Deadline in Securities Class Action Over Alleged Misstatements

Rosen Law Firm alerts $INO investors of April 7, 2026 deadline to join class action over alleged false statements regarding manufacturing and regulatory prospects.

INO
GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Enphase Energy Hit with Class Action Over Inventory Claims and Credit Cliff

Pomerantz Law Firm files class action against Enphase Energy over alleged misstatements regarding inventory management and federal solar tax credit impacts. Stock fell 15.15% after weak Q3 guidance.

ENPH
Benzinga

PSIX Securities Fraud Lawsuit: Data Center Claims Under Fire

Schall Law Firm seeks $PSIX investors for class action over alleged false statements on data center business and manufacturing costs. Deadline: May 19, 2026.

PSIX
GlobeNewswire Inc.

Mereo BioPharma Faces Class Action Over Failed Clinical Trials and Investor Losses

Mereo BioPharma faces class action lawsuit alleging misrepresentations regarding failed Phase 3 clinical trials, with lead plaintiff deadline April 6, 2026.

MREO